Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study

被引：0
|
作者：
Ross, Paul J.
Ma, Yuk Ting
Palmer, Daniel H.
Lythgoe, Mark Peter
Merrick, Sophie
Samson, Adel
Rao, Ankit Rohit
Basu, Bristi
Prasad, Debi
Dhillon, Tony
Lau, David
Darby, Suzanne
Orr, James
Margetts, Jane
Hubner, Richard
Baijal, Shobhit
Sharma, Rohini
Faluyi, Olusola Olusesan
Lee, Lennard
Thillai, Kiruthikah
机构：
[1] Guys & St Thomas NHS Fdn Trust, London, England
[2] Kings Coll Hosp NHS Fdn Trust, London, England
[3] Univ Birmingham, Birmingham, W Midlands, England
[4] Univ Liverpool, Liverpool, Merseyside, England
[5] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[6] Imperial Coll London, London, England
[7] East & North Herts NHS Trust, Stevenage, Herts, England
[8] Univ Leeds, Leeds, W Yorkshire, England
[9] Nottingham City Hosp, Nottingham, England
[10] Univ Cambridge, Cambridge, England
[11] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[12] Kings Coll Hosp London, London, England
[13] Univ Surrey, Royal Surrey Hosp, Guildford, Surrey, England
[14] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[15] Weston Pk Hosp, Sheffield, S Yorkshire, England
[16] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
[17] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[18] Christie NHS Fdn Trust, Manchester, Lancs, England
[19] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[20] Clatterbridge Canc Ctr, Wirral, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
499
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of radiotherapy combined with regorafenib for advanced hepatocellular carcinoma: A real-world study from a single center
    Xin, Lingxia
    Wang, Liming
    Zhai, Yirui
    Wang, Shulian
    Tang, Yuan
    Liu, Yueping
    Song, Yongwen
    Fang, Hui
    Li, Ning
    Qi, Shunan
    Lu, Ningning
    Li, Ye-Xiong
    Chen, Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Treatment modalities of regorafenib and survival in metastatic colorectal (mCRC) patients: A real-world multicenter retrospective study
    Qu, Wang
    Liu, Zimin
    Zhu, Liangjun
    Chen, Xiaobing
    Liu, Bo
    Zhao, Yun-Bo
    Yan, Hao
    Qu, Xiujuan
    Li, Shengmian
    Zang, Ai-Min
    Jiang, Zhichao
    Sun, Yongkun
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma
    Wang, Hung-Wei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Kao, Jung-Ta
    Hsu, Wei-Fan
    Chen, Hung-Yao
    Chang, Che-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05)
  • [44] A Real-World Experience on a Chinese Population of Patients With Unresectable Hepatocellular Carcinoma Treated With Nivolumab
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Lee, Teng-Yu
    GASTROENTEROLOGY RESEARCH, 2024, 17 (01) : 15 - 22
  • [45] Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study
    Lim, H. Y.
    Kim, Y. J.
    Huang, Y-H.
    Shao, G.
    Kim, D. Y.
    Cho, S. B.
    Hsu, C-H.
    Lin, S-M.
    Jeng, L-B.
    Kuo, K-K.
    Mao, Y.
    Zhu, K.
    Hong, Y. M.
    Lee, H. C.
    Ryoo, B-Y.
    Niu, Z.
    Wu, L.
    Fiala-Buskies, S.
    Kapur, S.
    Qin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1306 - S1307
  • [46] Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Final analysis of the prospective, observational REFINE study
    Kim, Y. J.
    Kurosaki, M.
    Numata, K.
    Lim, H. Y.
    Ikeda, M.
    Kudo, M.
    Huang, Y-H.
    Shao, G.
    Kato, N.
    Kim, D-Y.
    Cho, S-B.
    Hsu, C-H.
    Lin, S-M.
    Jeng, L-B.
    Kuo, K-K.
    Mao, Y.
    Chewaskulyong, B.
    Khan, J.
    Ozgurdal, K.
    Qin, S.
    ANNALS OF ONCOLOGY, 2022, 33 : S1459 - S1460
  • [47] Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study
    Merle, P.
    Lim, H. Y.
    Finn, R. S.
    Ikeda, M.
    Kudo, M.
    Frenette, C.
    Masi, G.
    Kim, Y. J.
    Gerolami, R.
    Kurosaki, M.
    Numata, K.
    Klumpen, H-J.
    Zebger-Gong, H.
    Fiala-Buskies, S.
    Ozgurdal, K.
    Qin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S699 - S700
  • [48] Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study
    Lim, H. Y.
    Kim, Y. J.
    Huang, Y-H.
    Shao, G.
    Kim, D. Y.
    Cho, S. B.
    Hsu, C-H.
    Lin, S-M.
    Jeng, L-B.
    Kuo, K-K.
    Mao, Y.
    Zhu, K.
    Hong, Y. M.
    Lee, H. C.
    Ryoo, B-Y.
    Niu, Z.
    Wu, L.
    Fiala-Buskies, S.
    Kapur, S.
    Qin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S699 - S699
  • [49] Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.
    Chan, Stephen Lam
    Ryu, Min-Hee
    Waked, Imam
    Shao, Yu Yun
    Tai, Wai Meng David
    Breder, Valeriy
    Alolayan, Ashwaq
    Ganguly, Sandip
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS618 - TPS618
  • [50] Real-world experience of paediatric acute promyelocytic leukaemia in the United Kingdom and Ireland
    Vedi, Aditi
    Leiter, Sarah Maria
    Memon, Irum Latif
    Mahendrayogam, Arunthethy
    Van Rijswijk, Elsje
    Uparkar, Urmila
    Shenton, Geoff
    Trinquand, Amelie
    Clesham, Katherine
    McLelland, Vanessa
    Campbell, Helen
    Patrick, Katharine
    Thompson, Lyndsey
    Baird, Susan
    Connor, Philip
    Lancaster, Donna
    James, Beki
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
12345